Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds CINC.
No tracked institution reports a position in CINC as of their last filing.
No one on the platform has traded CINC yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 2 of the last 4 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2022-11-03 | $-0.61 | $-0.51 | +16.4% |
| 2022-08-08 | $-0.50 | $-0.56 | -12.0% |
| 2022-05-10 | $-0.50 | $-0.50 | +0.0% |
| 2022-03-22 | $-1.56 | $-15.71 | -907.1% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| CINCCinCor Pharma, Inc. | $29.06 | +0.00% | $1.3B | — |
| ALBOAlbireo Pharma, Inc. | $44.15 | +0.00% | $916M | — |
| CTICCTI BioPharma Corp. | $9.10 | +0.06% | $1.2B | — |
| EQRXEQRx, Inc. | $2.34 | -2.09% | $1.1B | — |
| ETHZEthzilla Corp. | $3.53 | +0.00% | $56M | — |
| GRCLGracell Biotechnologies Inc. | $10.25 | +0.05% | $198M | — |
| PNTPOINT Biopharma Global Inc. | $12.50 | +0.16% | $1.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
$ABVX this guy does this all the time. This thing will be sold in the next 3 months... at $CINC stock was trading at 30 bucks, they release data and they mess up the saftey similar to what happened here, stock dumps to 11 bucks!!! 6 weeks later they sell the company at 30 bucks! Feels like this ceo is almost doing it on purpose lol!
View on StockTwits ↗
BofA⬆️the PT on $MLYS to $38 was $34 and reiterated at a Buy, says Lots of newsflow ahead, including near-term — Increasing PO to $38 following recent positive updates — ⬆️PoS for lorundrostat in hypertension to 80% from 50% $AZN - $CINC $LLY BofA said in its price target increase note:
View on StockTwits ↗BofA reiterated $MLYS Buy-$34, says Strong phase 3 data - from here, benefits most if it finds a partner — Solid data this morning — today's data heavily de-risking — data should support regulatory approval — will review its model — Broad benefit suggests uptake beyond obese hypertension — Still a debate: commercial plans and path forward $AZN - $CINC $LLY #ACC25 BofA said in its note to investors:
View on StockTwits ↗Stifel reiterated $MLYS Buy-$45, after $MLYS reported +VE study results, says "we see guideline AND practice-altering potential in these results." $AZN $CINC #ACC25 Stifel additionally said in its note to investors: " $MLYS has now reported out on 3 successful clinical studies—TARGET-HTN, ADVANCE-HTN, and LAUNCH-HTN—with high efficacy in both uncontrolled/resistant-HTN (u/rHTN) and notable consistency across populations studied. Specifically, the real-world LAUNCH (reported earlier-than-expected) and rigorously-designed ADVANCE drove -11.7 and -7.9 mmHg SBP reductions, respectively, in 3/4L populations that otherwise get only marginal benefit (-5-6 mmHg) from any additional add-on treatment. Stifel went on to say:
View on StockTwits ↗
$CINC CinCor Pharma, Inc. (CINC): Promising Pipeline, But Significant Losses and Cash Burn Raise Concerns https://beyondspx.com/article/cincor-pharma-inc-cinc-promising-pipeline-but-significant-losses-and-cash-burn-raise-concerns
View on StockTwits ↗$CINC CinCor Pharma, Inc. (CINC): Promising Pipeline, But Significant Losses and Cash Burn Raise Concerns http://beyondspx.com/2024/08/05/cincor-pharma-inc-cinc-promising-pipeline-but-significant-losses-and-cash-burn-raise-concerns/
View on StockTwits ↗
$IOVA $CINC $SIDU $TTOO $BBLG top runners
View on StockTwits ↗
$ALT Starting to remind me of my $RAIN play.... my $COSM call...my $CCXI before she fly...$CINC before the buyout....and a whack of others. Congrats longs!
View on StockTwits ↗
@paperjam One of the few that worked out well. Look at $ALBO and $CINC two recent examples where the management turned out a higher offer just a year earlier. This is a different market
View on StockTwits ↗
$CINC Form 15-12G (securities registration termination [section 12(g)]) filed with the SEC https://newsfilter.io/a/bf708addfc4d0b71c973abaab60afdfe
View on StockTwits ↗$CINC Form SC 13D/A (general statement of acquisition of beneficial ownership) filed with the SEC https://newsfilter.io/a/8d9ba7b4c65b2482d7959fa1524e8c94
View on StockTwits ↗$CINC Form SC 13D/A (general statement of acquisition of beneficial ownership) filed with the SEC https://newsfilter.io/a/e4fc7c4614bfeb9f2b31c7849e570c05
View on StockTwits ↗$CINC Form SC 13D/A (general statement of acquisition of beneficial ownership) filed with the SEC https://newsfilter.io/a/d78e020dc96c0415627530a26ff334e1
View on StockTwits ↗$CINC Form SC 13D/A (general statement of acquisition of beneficial ownership) filed with the SEC https://newsfilter.io/a/46cf39480a3fc18c5a517203d54a9ca1
View on StockTwits ↗$CINC Form 4 (statement of changes in beneficial ownership of securities) filed with the SEC https://newsfilter.io/a/b2e82c5b80ac3dd1ef3c0ef5b5a5698e
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.